Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 0 | 0 | 0 | 0 |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | 4.3M | 9.4M | 17.9M | 22.2M |
Selling general and admin | 5.2M | 6.2M | 7.6M | 5.9M |
Other operating expenses | — | — | — | — |
Operating income | -9.5M | -15.6M | -25.5M | -28.0M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | 393K | 563K | -3.2M | 1.2M |
Pretax income | -9.1M | -15.0M | -28.7M | -26.9M |
Tax provision | — | — | — | — |
Net income | -9.1M | -15.0M | -28.7M | -26.9M |
Basic EPS | -0.2 | — | -0.8 | -0.7 |
Diluted EPS | -0.2 | — | -0.8 | -0.7 |
Basic average shares | 39.0M | — | 38.5M | 38.4M |
Diluted average shares | 39.0M | — | 38.5M | 38.4M |
EBITDA | -9.3M | -15.3M | -21.1M | -27.8M |
Net income from continuing op. | -9.1M | -15.0M | -28.7M | -26.9M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | -41K | — |